Symbols / INBS Stock $2.76 -5.48% Intelligent Bio Solutions Inc.

Healthcare • Medical Devices • United States • NCM
INBS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Fundamentals
Scroll to Statements
Market Cap 6.01M Enterprise Value 5.41M Income -11.29M Sales 3.58M Book/sh 8.96 Cash/sh 0.46
Dividend Yield — Payout 0.00% Employees 53 IPO — P/E — Forward P/E 7.89
PEG — P/S 1.68 P/B 0.31 P/C — EV/EBITDA -0.55 EV/Sales 1.51
Quick Ratio 2.17 Current Ratio 2.38 Debt/Eq 17.67 LT Debt/Eq — EPS (ttm) -14.45 EPS next Y 0.35
EPS Growth — Revenue Growth 47.60% Earnings 2024-05-08 ROA -51.17% ROE -150.20% ROIC —
Gross Margin 46.21% Oper. Margin -290.89% Profit Margin 0.00% Shs Outstand 2.18M Shs Float 1.53M Short Float 2.23%
Short Ratio 0.94 Short Interest — 52W High 24.90 52W Low 2.42 Beta 4.59 Avg Volume 111.20K
Volume 77.35K Target Price — Recom None Prev Close $2.92 Price $2.76 Change -5.48%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.76
Latest analyst target
3. DCF / Fair value
$-120.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.76
Low
—
High
—
Mean
—
News
RSS: Latest INBS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-18 SAKIRIS SPIRO KEVIN Chief Financial Officer — 30,500 $0.00 $0
2026-03-18 HURD JONATHAN S Director — 5,000 $0.00 $0
2026-03-18 SIMEONIDIS HARRY Chief Executive Officer — 30,500 $0.00 $0
2026-03-18 BOYAGES STEVEN CONSTANTINE Director — 5,000 $0.00 $0
2026-03-18 ISENBERG JASON Director — 5,000 $0.00 $0
2026-03-18 FRASER NICOLA MARION Director — 5,000 $0.00 $0
2024-09-25 SAKIRIS SPIRO KEVIN Chief Financial Officer — 34,500 $0.00 $0
2024-09-25 SAKIRIS SPIRO KEVIN Chief Financial Officer — 34,500 — —
2024-09-25 SIMEONIDIS HARRY Chief Executive Officer — 40,000 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
3.05
-1.90%
3.11
+147.58%
1.26
0.00
Operating Revenue
3.05
-1.90%
3.11
+147.58%
1.26
0.00
Cost Of Revenue
1.81
+7.09%
1.69
+81.27%
0.93
0.00
Reconciled Cost Of Revenue
1.80
+7.49%
1.67
+80.00%
0.93
0.00
Gross Profit
1.25
-12.54%
1.43
+336.41%
0.33
0.00
Operating Expense
11.67
-0.32%
11.71
+33.61%
8.76
+5.11%
8.34
Research And Development
2.40
+43.18%
1.67
+229.86%
0.51
-86.83%
3.85
Selling General And Administration
8.88
-4.05%
9.26
+15.35%
8.03
+63.14%
4.92
General And Administrative Expense
—
—
—
4.92
Other Gand A
—
—
—
4.92
Other Operating Expenses
-0.82
-92.31%
-0.42
+42.41%
-0.74
-68.74%
-0.44
Total Expenses
13.48
+0.61%
13.39
+38.19%
9.69
+16.27%
8.34
Operating Income
-10.42
-1.37%
-10.28
-21.89%
-8.44
-1.20%
-8.34
Total Operating Income As Reported
-10.64
-3.51%
-10.28
+18.36%
-12.60
-51.08%
-8.34
EBITDA
-9.33
-5.90%
-8.81
+7.00%
-9.47
-13.79%
-8.33
Normalized EBITDA
-9.11
-1.38%
-8.99
-20.44%
-7.46
+10.36%
-8.32
Reconciled Depreciation
1.21
+0.05%
1.21
+25.48%
0.97
0.00
EBIT
-10.54
-5.19%
-10.02
+4.00%
-10.44
-25.40%
-8.33
Total Unusual Items
-0.22
-226.59%
0.17
+108.67%
-2.01
-50417.53%
-0.00
Total Unusual Items Excluding Goodwill
-0.22
-226.59%
0.17
+108.67%
-2.01
-50417.53%
-0.00
Special Income Charges
-0.22
0.00
+100.00%
-4.16
0.00
Impairment Of Capital Assets
0.22
0.00
-100.00%
4.16
0.00
Net Income
-10.57
-4.06%
-10.16
+4.47%
-10.63
-28.00%
-8.31
Pretax Income
-10.60
-4.06%
-10.19
+4.44%
-10.66
-27.96%
-8.33
Net Non Operating Interest Income Expense
0.04
+149.36%
-0.08
+61.51%
-0.21
-3205.24%
0.01
Interest Expense Non Operating
0.06
-63.57%
0.17
-25.23%
0.22
+2865.04%
0.01
Net Interest Income
0.04
+149.36%
-0.08
+61.51%
-0.21
-3205.24%
0.01
Interest Expense
0.06
-63.57%
0.17
-25.23%
0.22
+2865.04%
0.01
Interest Income Non Operating
0.10
+19.69%
0.08
+776.62%
0.01
-32.93%
0.01
Interest Income
0.10
+19.69%
0.08
+776.62%
0.01
-32.93%
0.01
Other Income Expense
-0.22
-226.59%
0.17
+108.67%
-2.01
-50417.53%
-0.00
Gain On Sale Of Security
-0.00
-100.52%
0.17
-91.86%
2.14
+53888.21%
-0.00
Tax Provision
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.60
-4.06%
-10.19
+4.44%
-10.66
-27.96%
-8.33
Net Income From Continuing Operation Net Minority Interest
-10.57
-4.06%
-10.16
+4.47%
-10.63
-28.00%
-8.31
Net Income From Continuing And Discontinued Operation
-10.57
-4.06%
-10.16
+4.47%
-10.63
-28.00%
-8.31
Net Income Continuous Operations
-10.60
-4.06%
-10.19
+4.44%
-10.66
-27.96%
-8.33
Minority Interests
0.04
+5.79%
0.03
+4.07%
0.03
+17.58%
0.03
Normalized Income
-10.35
-0.16%
-10.33
-19.89%
-8.62
-3.80%
-8.30
Net Income Common Stockholders
-10.57
-4.06%
-10.16
+4.47%
-10.63
-28.00%
-8.31
Diluted EPS
-20.00
+68.65%
-63.80
+94.98%
-1,270.00
+7.16%
-1,368.00
Basic EPS
-20.00
+68.65%
-63.80
+94.98%
-1,270.00
+7.16%
-1,368.00
Basic Average Shares
0.53
+231.10%
0.16
+1802.69%
0.01
+37.00%
0.01
Diluted Average Shares
0.53
+231.10%
0.16
+1802.69%
0.01
+37.00%
0.01
Diluted NI Availto Com Stockholders
-10.57
-4.06%
-10.16
+4.47%
-10.63
-28.00%
-8.31
Depreciation Amortization Depletion Income Statement
1.21
+0.55%
1.20
+24.26%
0.97
0.00
Depreciation And Amortization In Income Statement
1.21
+0.55%
1.20
+24.26%
0.97
0.00
Earnings From Equity Interest
—
—
—
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30
Total Assets
8.25
-40.13%
13.78
+33.07%
10.35
Current Assets
4.14
-51.51%
8.53
+120.95%
3.86
Cash Cash Equivalents And Short Term Investments
1.02
-83.82%
6.30
+310.09%
1.54
Cash And Cash Equivalents
1.02
-83.82%
6.30
+310.09%
1.54
Cash Financial
1.02
-83.82%
6.30
+310.09%
1.54
Receivables
1.60
+63.45%
0.98
+17.43%
0.83
Accounts Receivable
0.59
+38.38%
0.43
+46.23%
0.29
Gross Accounts Receivable
0.60
+36.36%
0.44
—
Allowance For Doubtful Accounts Receivable
-0.00
+91.94%
-0.01
—
Other Receivables
0.02
+217.39%
0.01
-68.69%
0.02
Taxes Receivable
0.98
+81.53%
0.54
+4.46%
0.52
Inventory
0.64
-18.30%
0.78
-20.65%
0.98
Raw Materials
—
0.19
-55.06%
0.42
Work In Process
0.21
+8.69%
0.19
—
Finished Goods
0.43
-26.95%
0.59
-22.27%
0.76
Prepaid Assets
0.49
+3.26%
0.47
-0.81%
0.48
Current Deferred Assets
0.07
0.00
-100.00%
0.03
Assets Held For Sale Current
0.33
0.00
—
Total Non Current Assets
4.11
-21.61%
5.24
-19.21%
6.49
Net PPE
0.32
-63.23%
0.87
-29.44%
1.24
Gross PPE
0.41
-56.18%
0.93
-26.53%
1.27
Accumulated Depreciation
-0.09
-45.07%
-0.06
-79.97%
-0.03
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.24
0.00
—
Construction In Progress
0.00
-100.00%
0.54
-15.90%
0.65
Other Properties
0.15
-59.16%
0.37
-38.78%
0.60
Leases
0.02
+8.69%
0.02
+0.02%
0.02
Goodwill And Other Intangible Assets
3.79
-13.31%
4.37
-16.81%
5.26
Other Intangible Assets
3.79
-13.31%
4.37
-16.81%
5.26
Non Current Accounts Receivable
—
—
—
Other Non Current Assets
—
—
—
Total Liabilities Net Minority Interest
5.44
-2.85%
5.60
-16.08%
6.67
Current Liabilities
5.35
-1.83%
5.45
-7.36%
5.88
Payables And Accrued Expenses
2.36
+38.58%
1.70
-29.02%
2.40
Payables
1.17
+6.82%
1.10
-8.26%
1.20
Accounts Payable
0.90
+48.96%
0.60
-49.65%
1.20
Current Accrued Expenses
1.19
+95.97%
0.61
-49.62%
1.21
Employee Benefits
0.08
+33.49%
0.06
+155.46%
0.02
Pensionand Other Post Retirement Benefit Plans Current
0.53
+13.98%
0.47
+30.77%
0.36
Total Tax Payable
0.08
+68.66%
0.05
0.00
Current Debt And Capital Lease Obligation
0.28
-64.33%
0.79
+37.02%
0.58
Current Debt
0.20
-61.74%
0.52
+45.89%
0.35
Other Current Borrowings
—
0.52
+45.89%
0.35
Current Capital Lease Obligation
0.08
-69.20%
0.27
+23.00%
0.22
Current Deferred Liabilities
2.17
-12.65%
2.49
-2.35%
2.55
Current Deferred Revenue
2.17
-12.65%
2.49
+6.36%
2.34
Other Current Liabilities
—
—
—
Total Non Current Liabilities Net Minority Interest
0.08
-41.41%
0.14
-81.51%
0.78
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.08
-89.29%
0.76
Long Term Debt
—
—
0.40
Long Term Capital Lease Obligation
0.00
-100.00%
0.08
-77.17%
0.36
Non Current Deferred Liabilities
—
—
0.00
Non Current Deferred Revenue
—
—
0.00
Stockholders Equity
3.00
-64.03%
8.33
+119.25%
3.80
Common Stock Equity
3.00
-64.03%
8.33
+119.25%
3.80
Capital Stock
0.07
+111.91%
0.03
+1679.45%
0.00
Common Stock
0.07
+111.91%
0.03
+1679.45%
0.00
Preferred Stock
—
—
0.00
Share Issued
0.73
+111.90%
0.35
+1679.70%
0.02
Ordinary Shares Number
0.73
+111.91%
0.35
+1680.65%
0.02
Treasury Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
Additional Paid In Capital
65.78
+7.89%
60.97
+32.03%
46.18
Retained Earnings
-62.53
-20.34%
-51.96
-24.29%
-41.81
Gains Losses Not Affecting Retained Earnings
-0.33
+53.98%
-0.71
-23.83%
-0.58
Treasury Stock
0.00
+0.00%
0.00
+0.00%
0.00
Minority Interest
-0.18
-24.74%
-0.15
-30.52%
-0.11
Other Equity Adjustments
-0.33
+53.98%
-0.71
-23.83%
-0.58
Total Equity Gross Minority Interest
2.81
-65.61%
8.18
+121.95%
3.69
Total Capitalization
3.00
-64.03%
8.33
+98.23%
4.20
Working Capital
-1.21
-139.32%
3.08
+252.56%
-2.02
Invested Capital
3.19
-63.90%
8.84
+94.17%
4.56
Total Debt
0.28
-67.66%
0.87
-34.76%
1.34
Capital Lease Obligations
0.08
-76.23%
0.36
-38.55%
0.58
Net Tangible Assets
-0.79
-120.07%
3.96
+371.72%
-1.46
Tangible Book Value
-0.79
-120.07%
3.96
+371.72%
-1.46
Current Notes Payable
0.20
-61.74%
0.52
—
Dueto Related Parties Current
0.19
-57.23%
0.44
—
Inventories Adjustments Allowances
—
0.00
+100.00%
-0.20
Notes Receivable
—
—
0.00
Preferred Stock Equity
—
—
—
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-9.68
-1.10%
-9.57
-29.74%
-7.38
-119.69%
-3.36
Cash Flow From Continuing Operating Activities
-9.68
-1.10%
-9.57
-29.74%
-7.38
-119.69%
-3.36
Net Income From Continuing Operations
-10.60
-4.06%
-10.19
+4.44%
-10.66
-27.96%
-8.33
Depreciation Amortization Depletion
1.21
+0.05%
1.21
+25.48%
0.97
0.00
Depreciation
1.21
+0.05%
1.21
+25.48%
0.97
0.00
Depreciation And Amortization
1.21
+0.05%
1.21
+25.48%
0.97
0.00
Other Non Cash Items
-0.02
+0.52%
-0.02
+89.12%
-0.22
-108.75%
2.54
Stock Based Compensation
0.24
+3.28%
0.23
-11.35%
0.26
0.00
Provisionand Write Offof Assets
0.00
-91.94%
0.01
-96.43%
0.19
0.00
Asset Impairment Charge
0.22
+215.84%
0.07
-98.32%
4.16
0.00
Operating Gains Losses
—
0.00
-88.02%
0.01
+346.53%
-0.00
Unrealized Gain Loss On Investment Securities
0.00
+100.00%
-0.18
+91.84%
-2.15
0.00
Net Foreign Currency Exchange Gain Loss
0.00
-100.00%
0.00
-88.02%
0.01
+346.53%
-0.00
Change In Working Capital
-0.72
-2.69%
-0.70
-989.45%
0.08
-96.76%
2.44
Change In Receivables
-2.86
-20620.37%
-0.01
-102.33%
0.59
-76.34%
2.50
Changes In Account Receivables
-0.16
-21.40%
-0.14
+53.77%
-0.29
0.00
Change In Inventory
0.14
-29.67%
0.20
+158.59%
-0.35
0.00
Change In Payables And Accrued Expense
2.58
+507.17%
-0.63
-849.04%
0.08
-65.18%
0.24
Change In Payable
—
-0.63
-849.04%
0.08
-65.18%
0.24
Change In Account Payable
—
-0.63
-849.04%
0.08
-65.18%
0.24
Change In Other Working Capital
0.02
+105.85%
-0.36
—
—
Change In Other Current Assets
-0.33
-696.54%
0.06
+146.66%
-0.12
+64.54%
-0.33
Change In Other Current Liabilities
-0.27
-628.34%
0.05
+138.45%
-0.13
-563.15%
0.03
Investing Cash Flow
-0.23
-4.70%
-0.22
+68.10%
-0.69
+21.14%
-0.88
Cash Flow From Continuing Investing Activities
-0.23
-4.70%
-0.22
+68.10%
-0.69
+21.14%
-0.88
Net PPE Purchase And Sale
-0.23
-4.70%
-0.22
+56.16%
-0.51
-32.85%
-0.38
Purchase Of PPE
-0.23
-4.70%
-0.22
+56.16%
-0.51
-32.85%
-0.38
Capital Expenditure
-0.23
-4.70%
-0.22
+56.16%
-0.51
-32.85%
-0.38
Net Investment Purchase And Sale
—
—
0.00
+100.00%
-0.50
Purchase Of Investment
—
—
0.00
+100.00%
-0.50
Net Business Purchase And Sale
—
0.00
+100.00%
-0.19
0.00
Purchase Of Business
—
0.00
+100.00%
-0.36
0.00
Net Other Investing Changes
—
—
—
-0.50
Financing Cash Flow
4.60
-68.42%
14.56
+914.44%
1.44
0.00
Cash Flow From Continuing Financing Activities
4.60
-68.42%
14.56
+914.44%
1.44
0.00
Net Common Stock Issuance
4.59
-64.43%
12.90
+405.15%
2.55
0.00
Proceeds From Stock Option Exercised
0.01
-99.52%
1.66
0.00
0.00
Net Other Financing Charges
—
—
-1.34
—
Changes In Cash
-5.31
-211.41%
4.77
+171.84%
-6.64
-56.58%
-4.24
Effect Of Exchange Rate Changes
0.03
+3941.16%
-0.00
+98.91%
-0.06
+33.22%
-0.10
Beginning Cash Position
6.30
+310.09%
1.54
-81.34%
8.24
-34.48%
12.57
End Cash Position
1.02
-83.82%
6.30
+310.09%
1.54
-81.34%
8.24
Free Cash Flow
-9.91
-1.19%
-9.79
-24.24%
-7.88
-110.86%
-3.74
Interest Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
4.59
-64.43%
12.90
+405.15%
2.55
0.00
Earnings Losses From Equity Investments
—
—
—
0.00
Issuance Of Capital Stock
4.59
-64.43%
12.90
+364.99%
2.78
0.00
Net Preferred Stock Issuance
—
0.00
-100.00%
0.22
0.00
Preferred Stock Issuance
—
0.00
-100.00%
0.22
0.00
Sale Of Business
—
0.00
-100.00%
0.17
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category